e-learning
resources
London 2016
Tuesday, 06.09.2016
Phenotyping and monitoring airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can emphysema predict exacerbations and changes in PFTs in COPD?
Zvi G Fridlender (Jerusalem, Israel), Zvi G. Fridlender, Ron Kaufman, Dorit Shaham, Neville Berkman
Source:
International Congress 2016 – Phenotyping and monitoring airway diseases
Session:
Phenotyping and monitoring airway diseases
Session type:
Thematic Poster
Number:
4182
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zvi G Fridlender (Jerusalem, Israel), Zvi G. Fridlender, Ron Kaufman, Dorit Shaham, Neville Berkman. Can emphysema predict exacerbations and changes in PFTs in COPD?. Eur Respir J 2016; 48: Suppl. 60, 4182
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Lung function change and exacerbations in patients with COPD in the WISDOM study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
The predictors for COPD exacerbations using remote patient monitoring
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Comparison of adventitious respiratory sounds between stable COPD and AECOPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Symptom profile of exacerbations in earlier and later COPD
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Validation of a four point sputum colour chart in chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept